Skip to main content
SpringerLink
Log in

Medical Risk and Benefit in Living Pancreas Segment Donors

  • Conference paper
Book cover Organ Replacement Therapy: Ethics, Justice Commerce

  • 121 Accesses

Abstract

Under conventional insulin therapy, morbidity and mortality in type I diabetic patients is still high [20]. Prerequisite for prevention of diabetic complications is long-term normoglycemia [5]. However, normal glucose homeostasis is up to now still only achievable with pancreatic grafting [10]. In recent years, pancreatic transplantation is quite a safe and successful mode of treatment for carefully selected type I diabetics [13,14,17].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barbosa J, King R, Noreen H, Yunis EJ (1977) The histocompatibility system in juvenile insulin-dependent diabetic multiplex kindreds. J Clin Invest 60:989–998.

    Article  Google Scholar 

  2. Bolinder J, Gunnarsson R, Tydén G, Brattström C, Östman J, Groth CG (1988) Metabolic effects of living related pancreatic graft donation. Transplant Proc 20:475–478.

    Google Scholar 

  3. Chinn PL, Sutherland DER, Goetz FC, Oliphant UJ, Elick BA, Najarian JS (1984) Metabolic effect of hemipancreatectomy in living related graft donors. Transplatn Proc 16:11–17.

    Google Scholar 

  4. Dubernard JM, Sutherland DER (eds) (1989) International Handbook of Pancreas Transplantation. Kluwer, Dordrecht.

    Google Scholar 

  5. Hanssen KF, Dahl Jørgensen K, Lauritzen T, Feldt-Rasmussen B, Brinchmann-Hansen O, Deckert T (1986) Diabetic control and microvascular complications: The nearnormoglycemic experience. Diabetologia 29:677–684.

    Article  Google Scholar 

  6. ImamuraT, Koffler M, Helderman JH, Prince D, Thirlby R, Inman L, Unger RH (1988) Severe diabetes induced in subtotally depancreatized dogs by sustained hyperglycemia. Diabetes 37:600–609.

    Article  Google Scholar 

  7. Kendall DM, Sutherland DER, Goetz FC, Najarian JS (1989) Metabolic effect of hemipancratectomy in donors. Preoperative prediction of postoperative oral glucose tolerance. Diabetes 38 [Suppl 1]:101–103.

    Google Scholar 

  8. Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP (1990) Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. N Engl J Med 322:898–903.

    Article  Google Scholar 

  9. Köbberling J, Tillil H (1982) Empirical risk figures for first degree relatives of non-insulin dependent diabetics. In: Köbberling J and Tattersall R (eds) The genetics of diabetes mellitus. Academic, London, pp 201–209.

    Google Scholar 

  10. Landgraf R, Nusser J, Scheuer R, Fiedler A, Scheider A, Meyer-Schwickerath E, Miiller-Felber W, Illner WD, Abendroth D, Land W (1989) Metabolic control and effect of secondary complications of diabetes mellitus by pancreatic transplantation. Ballière’s Clinical Gastroenterology 3:865–876.

    Article  Google Scholar 

  11. Leaky JL, Bonner Weir S, Weir GC (1988) Minimal chronic hyperglycemia is a critical determinant of impaired insulin secretion after an incomplete pancreatectomy. J Clin Invest 81:1407–1414.

    Article  Google Scholar 

  12. Mizumoto R, Kawarada Y, Goshima H, Tamaki T, Sekoguchi T, Tomikawa J (1982) Carbohydrate metabolism and endocrine function in the pancreas remnant after major pancreatic resection. Am J Surgery 143:237–243.

    Article  Google Scholar 

  13. Land W, Landgraf R (1987) Clinical pancreas transplantation: The world experience. Transplant Proc 19 [Suppl 4]:1–102.

    Google Scholar 

  14. Najarian JS, Sutherland DER, Groth CG (Guest Eds) (1990) Second International Congress on Pancreatic and Islet Cell Transplantation. Transplant Proc 22:569–883.

    Google Scholar 

  15. Sun AM, Coddling JA, Haist RE (1974) A study of glucose tolerance and insulin response in partially depancreatized dogs. Diabetes 23:424–432.

    Google Scholar 

  16. Sutherland DER, Sibley R, Chinn P, Michael A, Srikanta S, Taub F, Najarian J, Goetz FC (1984) Twin to twin pancreas transplantations: reversal and reenactment of the pathogenesis of type I diabetes. Clin Res 32:56.

    Google Scholar 

  17. Sutherland DER, Dunn DL, Goetz FC, Kennedy W, Ramsay RC, Steffes MW, Mauer SM, Gruessner R, Moudry-Munns KC, Morel P, Viste A, Robertson RP, Najarian JS (1989) 10-year experience with 290 pancreas transplants at a single institution. Ann Surgery 210:274–288.

    Article  Google Scholar 

  18. Ward WK, Wallum BJ, Beard JC, Taborsky Jr GJ, Porte Jr D (1988) Reduction of glycemic potentiation. Sensitive indicator of β-cell loss in partially pancreatectomized dogs. Diabetes 37:723–729.

    Article  Google Scholar 

  19. Weir GC, Bonner Weir S, Leaky JL (1990) Islet mass and function in diabetes and transplantation. Diabetes 39:401–405.

    Article  Google Scholar 

  20. WHO Study Group (1985) Diabetes mellitus. WHO Technical Report Series 727.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Klinikum Innenstadt, University of Munich, Ziemssenstraße 1, D-8000, München 2, Germany

    R. Landgraf

Authors
  1. R. Landgraf
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung für Transplantationschirurgie, Ludwig-Maximilians-Universität, Klinikum Großhadern, 8000, München 70, Germany

    Walter Land

  2. Joint-Faculties Bioethics Project, 222, 11420 University Avenue, Edmonton, Alberta, T6G 2J3, Canada

    John B. Dossetor M. D.

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Landgraf, R. (1991). Medical Risk and Benefit in Living Pancreas Segment Donors. In: Land, W., Dossetor, J.B. (eds) Organ Replacement Therapy: Ethics, Justice Commerce. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76444-8_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-76444-8_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-76446-2

  • Online ISBN: 978-3-642-76444-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation